UNSPSC 51422509: Hydrocortamate

This classification denotes a therapeutic glucocorticoid with the molecular formula C27H41NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y3N00BK5WK, chemically known as 17-hydroxycorticosterone, 21-(diethylamino)acetate but generally known as hydrocortamate, which bears US NIH Compound Identifier 84088. European Medicines Agency schedules Hydrocortamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08064MIG. The term HYDROCORTAMATE is an International Non-Proprietary Name.

UNSPSC 51422509 Hydrocortamate is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The most recent opportunity on record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023—solicits naloxone and safe drug deactivation systems for community health initiatives, not hydrocortamate. The mismatch suggests either a tagging error in the source database or that Seminole County's procurement office applied an incorrect UNSPSC code to a naloxone and harm-reduction procurement. The code shows no other recent state or local opportunities in the source material and no meaningful activity under its nominal scope.

Seminole County's naloxone IFB is the sole recent record and does not support a broader issuing-body mix, geographic spread, or market characterization for this code. Given the single misaligned opportunity and the absence of additional relevant activity, this Commodity code appears dormant in current state and local procurement.